Swedish Auto Stock News

Insiders who bought kr654.1k worth of Cinclus Pharma Holding AB (publ) ( STO:CINPHA ) stock in the last year have seen...

Cibus Real Estate AB (publ) ( STO:CIBUS ) stock is about to trade ex-dividend in three days. The ex-dividend date is...

Attendo stock walked into this earnings print with a quietly strong run, up about 7% over the past week and 6% over the month. The mood was already optimistic. The headline from the results is clear. Profitability metrics moved to the center of the story as lease adjusted EBITA jumped to SEK 321m and the rolling 12 month lease adjusted EBITA margin reached 7.8%. For a care operator where occupancy and margins drive the equity story, that is what the market is trading on today. Is Attendo’s...

The market has marked New Wave Group down over the past three months, with the stock falling about 9.9% to close near SEK89.55 on Friday. Yet the latest earnings print tells a calmer story. Q2 revenue landed at SEK2,611m with net income of SEK202m, and management framed operating profitability as “very, very good” despite an ongoing investment phase. The real tension for investors sits in margins. Trailing net profit margin is reported at 7.7%, lower than a year earlier, at the same time as...

Better Collective stock came into this print on the back foot, down over the past week and month, yet the Q2 numbers tell a very different story. The headline is clear for a digital betting affiliate. Revenue reached €89.1m while EBITDA before special items landed at €27m with a 30% margin and cash conversion of 111%. The market is reacting to a stock that already carried a premium P/E and high debt, while the results themselves underline solid profitability and cash generation. The gap...

Catella came into this print with the stock under pressure, down about 11% over 3 months and closing at SEK18.28 on 21 August. The long term story has been about a discounted real estate platform with potential upside to a turn in European property markets. The headline from Q2 goes straight to that thesis. Revenue landed at SEK406m and Catella again reported a loss, roughly SEK12m, yet the main focus is the squeeze on underlying profitability once a sizeable SEK50m foreign exchange tailwind...

The market has spent the past month pushing Fasadgruppen Group down about 6% and roughly 10% over three months, yet Q2 landed with a very different message. The stock closed at SEK18.88 going into the release, while the business produced SEK1,412.4m of revenue and returned to a quarterly profit with basic earnings per share of SEK0.71. For a construction services group that has been wrestling with losses over the past year, that margin squeeze story is what traders are reacting to today. The...

The market has been rewarding KABE Group AB (publ.) ahead of this release, with the stock up roughly 25% over the past 90 days, yet Q2 numbers tell a more grounded story. The headline is margin and profit pressure easing rather than rapid growth. KABE Group reported Q2 2026 revenue of SEK 1,021 million and net income of SEK 72 million, which puts basic earnings per share at SEK 8. For a cyclical vehicle and leisure products manufacturer, the key signal is that profitability looks healthier...

Bure Equity stock has quietly climbed in recent weeks, yet the real shock arrived in the earnings. After a long run of losses, Q2 showed a sharp swing back into profit with basic earnings per share at SEK102.43 and net income close to SEK7.6b. That is a psychological gear shift for a market that had grown used to red ink. At a P/E of 4.4x against a much higher European capital markets average, investors now face a classic sentiment test: Is this just a relief bounce or the market underpricing...

Boliden (OM:BOL) is back in focus after the Swedish government rejected two appeals against its mining concession for the Laver project, confirming rights to extract copper, gold, silver and molybdenum. See our latest analysis for Boliden. Boliden’s latest regulatory win comes after a strong run, with the share price at SEK539.4 and short term momentum reflected in a 13.13% 1 month share price return, while the 1 year total shareholder return is 73.56%. If this kind of copper exposure...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Surgical Science Sweden heads into this earnings reaction with a strong recent share run, up about 62% over the past month, yet still trading around SEK49.3. The stock carries a premium P/E of 27x on trailing earnings, while the latest discounted cash flow estimate sits far higher than the current price. Q2 results land in the middle of that debate. Revenue reached about SEK254.5m and adjusted profitability hit the company’s 15% EBIT target, powered by a rich 69% gross margin and strong...

BICO Group stock has climbed 41.1% over the past month to close at SEK19.28 on Thursday, which indicates that traders are already repositioning around the story. The headline today is not a sudden return to profit; it is a sharp easing of the earnings squeeze. Quarterly revenue landed at SEK336.1m while the company still reported a loss, with basic earnings per share at SEK0.53 in the red. The key message for longer term holders is that profit pressure remains heavy, even as the latest...

Beijer Ref (OM:BEIJ B) shares are in focus after the company announced that CFO Joel Davidsson will step in as acting CEO and president from 14 August 2026, succeeding Christopher Norbye. See our latest analysis for Beijer Ref. The CEO transition comes as Beijer Ref shares trade at SEK127.0, with the share price falling 10.5% over the past 30 days and the 1 year total shareholder return declining 25.4%, while the 3 year total shareholder return remains slightly positive. If leadership change...

The European market has recently been navigating a complex landscape, with resilient economic data and solid corporate earnings being balanced against geopolitical uncertainties. In this context, growth companies with high insider ownership can be particularly appealing, as they often indicate strong confidence from those who know the business best.

Skanska (OM:SKA B) is back in focus after a series of large United States contract wins, highlighted by a joint venture agreement for the East San Fernando Valley Light Rail Transit Project in Los Angeles. See our latest analysis for Skanska. Set against this run of large United States contract wins and leadership changes, Skanska’s share price at SEK262.3 reflects a 1-month share price return of 1.98% and a 3-month share price return of 7.32%. Its 1-year total shareholder return of 15.42%...

The new licensing agreement between PayRange and Electrolux Professional to embed mobile payments in commercial laundry systems has pushed AB Electrolux (OM:ELUX B) back into focus as investors reassess margins, cash flow and valuation. See our latest analysis for AB Electrolux. At a share price of SEK28.34, AB Electrolux has seen a 1 month share price return of 22.79%, while the 1 year total shareholder return is down 13.42% and the 5 year total shareholder return is down 71.88%. This...

The mRNA cancer vaccine breakthrough from Moderna and Merck has pushed this once speculative corner of biotech into the spotlight, and investors are taking notice of how quickly expectations can reset when trial data shifts the story. That kind of sharp repricing can create both opportunity and risk if you are exposed to similar news. This article walks through 3 stocks linked to this catalyst so you can judge whether they still fit your portfolio. The three stocks below are a useful sample...

As European markets navigate geopolitical uncertainties and fluctuating energy prices, the pan-European STOXX Europe 600 Index recently experienced a slight decline. However, resilient economic data and solid corporate earnings provide a foundation for identifying undervalued stocks that may offer potential value opportunities in this complex landscape.

As European markets navigate resilient economic data and geopolitical uncertainties, the pan-European STOXX Europe 600 Index recently experienced a slight decline, reflecting investor caution. Amidst these conditions, growth companies with high insider ownership often attract attention due to their potential alignment of interests and confidence in long-term prospects.

As European markets navigate a landscape marked by resilient economic data and geopolitical uncertainties, the pan-European STOXX Europe 600 Index recently experienced a slight decline. Amid these conditions, investors are increasingly drawn to dividend stocks that offer potential income stability and resilience against market volatility.

As global markets navigate a complex landscape marked by easing inflation concerns, fluctuating oil prices, and mixed consumer data, small-cap indices like the Russell 2000 and S&P MidCap 400 have shown resilience with notable gains. Amid this backdrop, investors are increasingly seeking hidden opportunities within the small-cap segment that can offer potential growth despite broader market uncertainties. In such an environment, identifying promising stocks involves looking for companies...

It's been a good week for BTS Group AB (publ) ( STO:BTS B ) shareholders, because the company has just released its...

Swedish Orphan Biovitrum (OM:SOBI) has moved into rare oncology with a new agreement with Innate Pharma that supports the TELLOMAK-3 Phase 3 trial of lacutamab in cutaneous T cell lymphoma. See our latest analysis for Swedish Orphan Biovitrum. The Innate Pharma agreement comes as Swedish Orphan Biovitrum trades at SEK457.8, with a year to date share price return of 38.56% and a 1 year total shareholder return of 62.92%. This suggests momentum has been building over the past year. If this move...